货号:GS40606
Riliprubart is a humanized IgG4 kappa monoclonal antibody targeting complement component 1s (C1s). It inhibits C1s to block classical complement pathway activation, reducing inflammation and tissue damage. It is being developed for autoimmune and complement-mediated disorders such as cold agglutinin disease and lupus nephritis.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯